An overview of radioimmunotherapy
- 1 March 1991
- journal article
- review article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 34 (2) , 71-73
- https://doi.org/10.1007/bf01741338
Abstract
In reviewing the current state of affairs in radioimmunotherapy the paper focuses on the main difficulties thus far encountered and the procedures designed to avoid or circumvent these problems. The long range β-emitters90Y and188Re have replaced131I as the isotopes currently receiving most attention for use in radioimmunotherapy, and a range of new chelators are under investigation for in vivo stability and immunogenicity. Approaches aimed at improving tumour targetting and antigen expression such as two-step pretargetting techniques, tumour necrosis treatment and cytokine pretreatment are summarised. Methods designed to improve host-Mab interactions are outlined and the need to incorporate successful ideas from current cancer therapies is emphasised.Keywords
This publication has 17 references indexed in Scilit:
- Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection.1991
- Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodies.1990
- YTTRIUM-90-LABELED MONOCLONAL-ANTIBODY FOR THERAPY - LABELING BY A NEW MACROCYCLIC BIFUNCTIONAL CHELATING AGENT1990
- Human monoclonal antibodies: their potential, problems, and prospects.1989
- Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibodyNuclear Medicine Communications, 1988
- The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complexJournal of the American Chemical Society, 1988
- Dosimetric aspects of radiolabeled antibodies for tumor therapy.1986
- Induction of tolerance by monoclonal antibody therapyNature, 1986
- Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodiesMedical Physics, 1984
- Selective Cytotoxicity of Hapten-Substituted Cells with an Antibody-Enzyme ConjugateThe Journal of Immunology, 1973